Daewoong Co., Ltd. (KRX:003090)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Manufacturing and Sales	2.07T	1.96T	1.83T	1.61T	1.45T
Pharmaceutical Manufacturing and Sales Growth	5.69%	7.04%	13.79%	10.70%	-3.92%
Real Estate Rental	14.11B	10.86B	6.31B	4.48B	5.36B
Real Estate Rental Growth	29.88%	72.21%	40.69%	-16.41%	-40.71%
Service Provision	115.69B	114.12B	96.96B	83.15B	75.07B
Service Provision Growth	1.38%	17.70%	16.61%	10.76%	-1.83%
Others	12.51B	8.76B	8.43B	7.21B	6.98B
Others Growth	42.78%	3.97%	16.85%	3.37%	83.69%
Consolidation Adjustment	-278.04B	-281.03B	-246.50B	-193.54B	-186.48B
Total	1.94T	1.81T	1.70T	1.51T	1.36T
Total Growth	6.79%	6.86%	12.30%	11.51%	-0.76%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Unallocated	306.63B	266.25B	-	-	-
Unallocated Growth	15.16%	-	-	-	-
The Republic of Korea	1.91T	1.83T	-	1.52T	1.35T
The Republic of Korea Growth	4.36%	-	-	12.83%	-
Consolidation	-278.04B	-281.03B	-	-193.54B	-151.43B
Export	-	-	-	185.62B	160.20B
Export Growth	-	-	-	15.87%	-
Total	1.94T	1.81T	-	1.51T	1.36T
Total Growth	6.79%	-	-	11.51%	-

Source: S&P Global Market Intelligence.